Table 2:
Variable | Odds Ratio (95% Confidence Interval) | p-value |
---|---|---|
Demographics | ||
Age 35–50 vs. Age 18–35 | 1.62 (0.73–3.58) | 0.23 |
Age 50–65 vs. Age 18–35 | 2.49 (1.17–5.27) | 0.02 |
Age ≥65 vs. Age 18–35 | 6.21 (2.94–13.11) | <0.001 |
Male vs. Female | 1.11 (1.04–1.19) | 0.002 |
Black vs. White | 0.65 (0.57–0.73) | <0.001 |
Hispanic vs. White | 0.73 (0.63–0.84) | <0.001 |
Other vs. White | 1.01 (0.92–1.12) | 0.82 |
Income Group (centile) | ||
<25th vs. >75th | 0.97 (0.87–1.08) | 0.58 |
25th-50th vs. >75th | 0.95 (0.87–1.04) | 0.28 |
50th-75th vs. >75th | 0.97 (0.89–1.06) | 0.50 |
Comorbidities | ||
Alcohol Abuse | 1.25 (1.01–1.54) | 0.04 |
Anemia | 1.29 (1.18–1.40) | <0.001 |
Chronic Kidney Disease | 0.98 (0.89–1.08) | 0.69 |
Chronic Pulmonary Disease | 1.22 (1.13–1.31) | <0.001 |
Coronary Artery Disease | 1.12 (1.03–1.22) | 0.006 |
Prior Percutaneous Coronary | 0.79 (0.72–0.86) | <0.001 |
Intervention | ||
Prior Coronary Artery Bypass Grafting | 0.78 (0.71–0.86) | <0.001 |
Diabetes Mellitus | 0.76 (0.71–0.83) | <0.001 |
Dyslipidemia | 0.87 (0.82–0.93) | <0.001 |
End-Stage Renal Disease | 0.97 (0.83–1.14) | 0.71 |
History of Heart Failure | 2.02 (1.86–2.20) | <0.001 |
History of Venous Thromboembolism | 0.89 (0.74–1.08) | 0.24 |
Hypertension | 1.0 (0.92–1.08) | 0.97 |
Malignancy | 0.96 (0.78–1.17) | 0.68 |
Obesity | 1.08 (0.97–1.19) | 0.15 |
Peripheral Arterial Disease | 1.15 (1.06–1.24) | <0.001 |
Tobacco Use | 0.87 (0.81–0.94) | <0.001 |
Valvular Heart Disease | 1.77 (1.52–1.85) | <0.001 |
Surgery Type | ||
General Surgery | Reference | |
Genitourinary | 0.42 (0.36–0.49) | <0.001 |
Skin/Burn | 0.29 (0.22–0.38) | <0.001 |
Neurosurgery | 0.45 (0.38–0.55) | <0.001 |
Obstetric | 0.16 (0.12–0.22) | <0.001 |
Orthopedic | 0.37 (0.34 –0.40) | <0.001 |
Other Surgeries | 0.40 (0.32–0.51) | <0.001 |
Thoracic | 2.08 (1.84–2.35) | <0.001 |
Vascular | 0.63 (0.58–0.70) | <0.001 |
The C-statistic was 0.85 for this model.